Alexandria Real Estate Equities, Inc. (ARE) — SEC Filings
Alexandria Real Estate Equities, Inc. (ARE) — 35 SEC filings. Latest: 8-K (Dec 8, 2025). Includes 18 8-K, 7 SC 13G/A, 6 10-Q.
View Alexandria Real Estate Equities, Inc. on SEC EDGAR
Overview
Alexandria Real Estate Equities, Inc. (ARE) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Dec 3, 2025: Alexandria Real Estate Equities, Inc. (ARE) filed an 8-K on December 3, 2025, reporting on events that occurred on the same date. The filing primarily concerns Regulation FD disclosures and financial statement exhibits, with no specific material events detailed in the provided excerpt.
Sentiment Summary
Across 35 filings, the sentiment breakdown is: 1 bearish, 33 neutral, 1 mixed. The dominant filing sentiment for Alexandria Real Estate Equities, Inc. is neutral.
Filing Type Overview
Alexandria Real Estate Equities, Inc. (ARE) has filed 18 8-K, 6 10-Q, 2 DEF 14A, 1 10-K, 7 SC 13G/A, 1 SC 13D/A with the SEC between Jan 2024 to Dec 2025.
Filings by Year
Recent SEC Filings (35)
Risk Profile
Risk Assessment: Of ARE's 22 recent filings, 1 were flagged as high-risk, 7 as medium-risk, and 14 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $751.9M |
| Net Income | -$197.8M |
| EPS | -$1.38 |
| Debt-to-Equity | 0.77 |
| Cash Position | $579.5M |
| Operating Margin | N/A |
| Total Assets | $37.38B |
| Total Debt | $13.59B |
Key Executives
- Joel S. Marcus
- Peter M. Moglia
- Stephen A. Richardson
- Sara M. Human-Vogelsang
- Joel S. Resnick
- Daniel S. Ryan
Industry Context
Alexandria Real Estate Equities, Inc. operates as a pioneer in the life science real estate niche, focusing on developing collaborative 'Megacampus' ecosystems in key innovation clusters. The company is a leading owner, operator, and developer in this specialized sector, which requires significant capital investment and long-term development cycles. The industry is characterized by high demand for specialized facilities driven by biotech and pharmaceutical research and development.
Top Tags
disclosure (6) · real-estate (6) · amendment (5) · 8-K (4) · sec-filing (4) · corporate-governance (4) · compensation (4) · institutional-ownership (4) · passive-investment (4) · REIT (3)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| SEC File Number | 1-12993 | Identifies the company's filing with the SEC. |
| I.R.S. Employer Identification No. | 95-4502084 | Company's tax identification number. |
| Net Loss Attributable to Common Stockholders | $234.9M | For the three months ended September 30, 2025, a significant decline from $164.7 million net income in Q3 2024. |
| Real Estate Impairment | $323.9M | For the three months ended September 30, 2025, a substantial increase from $5.7 million in Q3 2024, driving the net loss. |
| Real Estate Impairment (Nine Months) | $485.6M | For the nine months ended September 30, 2025, a significant increase from $36.5 million in the prior year. |
| Total Revenues | $751.9M | For the three months ended September 30, 2025, a decrease from $791.6 million in Q3 2024. |
| Basic Net Loss Per Share | $1.38 | For the three months ended September 30, 2025, compared to $0.96 basic net income per share in Q3 2024. |
| Interest Expense (Nine Months) | $161.0M | For the nine months ended September 30, 2025, an increase from $130.2 million in the prior year. |
| Total Assets | $37.4B | As of September 30, 2025, a slight decrease from $37.5 billion as of December 31, 2024. |
| Cash and Cash Equivalents | $579.5M | As of September 30, 2025, an increase from $552.1 million as of December 31, 2024. |
| Central Index Key | 0001035443 | Unique identifier for the filer |
| Fiscal Year End | 2024 | The filing covers the company's performance and governance for this period. |
| Filing Date | 20250402 | This is the date the DEF 14A was officially submitted to the SEC. |
| Annual Base Salary | $375,000 | For the newly appointed Chief Accounting Officer, Sara M. Human-Vogelsang. |
| Commission File Number | 1-12993 | SEC identifier for the company |
Forward-Looking Statements
- {"claim":"Vanguard will maintain a significant, albeit passive, stake in Alexandria Real Estate Equities Inc. for the foreseeable future.","entity":"The Vanguard Group","targetDate":"December 29, 2024","confidence":"high"}
Related Companies
Frequently Asked Questions
What are the latest SEC filings for Alexandria Real Estate Equities, Inc. (ARE)?
Alexandria Real Estate Equities, Inc. has 35 recent SEC filings from Jan 2024 to Dec 2025, including 18 8-K, 7 SC 13G/A, 6 10-Q. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of ARE filings?
Across 35 filings, the sentiment breakdown is: 1 bearish, 33 neutral, 1 mixed. The dominant sentiment is neutral.
Where can I find Alexandria Real Estate Equities, Inc. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Alexandria Real Estate Equities, Inc. (ARE) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Alexandria Real Estate Equities, Inc.?
Key financial highlights from Alexandria Real Estate Equities, Inc.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for ARE?
The investment thesis for ARE includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Alexandria Real Estate Equities, Inc.?
Key executives identified across Alexandria Real Estate Equities, Inc.'s filings include Joel S. Marcus, Peter M. Moglia, Stephen A. Richardson, Sara M. Human-Vogelsang, Joel S. Resnick and 1 others.
What are the main risk factors for Alexandria Real Estate Equities, Inc. stock?
Of ARE's 22 assessed filings, 1 were flagged high-risk, 7 medium-risk, and 14 low-risk.
What are recent predictions and forward guidance from Alexandria Real Estate Equities, Inc.?
Recent forward-looking statements from Alexandria Real Estate Equities, Inc. include guidance on {"claim":"Vanguard will maintain a significant, albeit passive, stake in Alexandria Real Estate Equities Inc. for the fo.